Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 9, 2009

HIHG Taps Life Technologies’ Sequencing Platforms for Autism Research

  • The University of Miami Miller School of Medicine's John P. Hussman Institute for Human Genomics will use Life Technologies’ products to search for genes that cause autism. The institute purchased two next-generation sequence systems from Applied Biosystems, part of Life Technologies. 

    The two SOLiD™ System sequencing platforms will be initially used to investigate genes that showed association with autism in their genome-wide study. “What we've been able to do with genotyping has been phenomenal, but it only gives us a portion of the information we need to identify and understand the genetic causes underlying human disease,” says senior co-investigator John R. Gilbert, Ph.D. “Sequencing gets to those causes.”



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »